TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
OMCL

Omnicell Inc

Healthcare · Health Information Services

33.20$ +2.3% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios OMCL
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
39.7 37.1 2,072.5 91.1 65.8 57.2 163.0 111.1 409.5 164.3 1,023.5
2.7 2.4 1.8 2.6 3.2 3.9 5.9 7.6 1.8 1.5 1.9 1.8
3.1 2.8 2.9 3.6 3.7 4.2 5.4 7.5 2.0 1.4 1.7 1.7
2.5 2.2 2.1 2.9 3.3 3.8 5.9 7.8 2.0 1.6 1.8 1.8
15.6 14.9 22.4 32.8 26.7 24.2 48.9 50.8 26.4 17.0 20.5
28.5 83.5 66.6 50.1 42.1 40.1 42.6 135.7 12.2 13.6 24.2
3.5% 1.2% 1.5% -0.3% 2.0% 2.4% 2.5% 2.3% 0.7% 8.2% 7.3% 4.1%
Margins
53.0% 51.2% 45.3% 45.0% 47.3% 48.7% 46.3% 49.0% 45.4% 43.3% 42.3% 42.9%
11.2% 10.0% 0.9% 0.8% 5.6% 8.7% 4.0% 7.9% -0.2% -3.0% 0.0% 1.0%
6.9% 6.3% 0.1% 2.9% 4.8% 6.8% 3.6% 6.9% 0.4% -1.8% 1.1% 0.2%
9.7% 2.8% 2.7% -0.8% 6.3% 9.3% 14.7% 17.9% 1.3% 12.2% 13.6% 7.3%
Returns
7.8% 7.6% 0.1% 4.0% 5.6% 7.3% 3.3% 6.8% 0.5% -1.7% 1.0% 0.2%
5.4% 5.3% 0.1% 2.1% 3.5% 4.9% 1.8% 3.6% 0.3% -0.9% 0.6% 0.1%
Balance Sheet & Debt
-121 -74 200 178 77 -67 -6.5 152 247 112 -18 -17
-1.7 -1.0 3.1 2.8 0.8 -0.5 -0.1 0.9 2.6 -0.1 -0.2
69.6% 69.5% 46.2% 52.8% 62.9% 68.1% 53.0% 53.5% 51.1% 53.4% 58.6% 62.4%
0.0 0.0 0.6 0.4 0.2 0.1 0.5 0.4 0.5 0.5 0.3 0.1
Per Share
0.83 0.84 0.02 0.53 0.93 1.43 0.74 1.62 0.12 -0.45 0.27 0.04
12.04 13.20 18.79 18.50 19.41 20.89 20.40 23.61 28.24 25.37 24.05 25.56
10.65 10.96 11.71 13.36 16.76 19.68 22.12 23.92 24.63 26.30 26.88 26.57
1.16 0.37 0.51 -0.15 1.22 1.94 2.99 4.23 0.37 3.09 3.27 1.87

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?